罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08058 罗欣药业

退市 06-05 15:59:45

16.960

-0.020

-0.12%

最高16.980	最低16.940	成交量72.00万
今开16.940	昨收16.980	日振幅0.24%
总市值103.39亿	流通市值27.91亿	总股本6.10亿
成交额1,221万	换手率0.44%	流通股本1.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"罗欣药业","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"floatShares":164560000,"shares":609600000,"eps":0.6861785981075699,"marketStatus":"退市","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":7,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08058","defaultTab":"news","newsList":[{"id":"2590677165","title":"罗欣药业：截止至2025年12月10日股东总户数为39,227","url":"https://stock-news.laohu8.com/highlight/detail?id=2590677165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590677165?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:06","pubTimestamp":1765436785,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日公司股东人数多少？罗欣药业回复：尊敬的投资者，您好！截止至2025年12月10日，公司股东总户数为39,227。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0132","BK0001","002793","08058"],"gpt_icon":0},{"id":"2588477558","title":"罗欣药业（002793）披露2024年员工持股计划首次授予部分第一个锁定期届满暨解锁条件成就公告，12月01日股价下跌0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588477558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588477558?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:23","pubTimestamp":1764599011,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，罗欣药业报收于5.38元，较前一交易日下跌0.55%，最新总市值为58.51亿元。该股当日开盘5.41元，最高5.44元，最低5.36元，成交额达6870.54万元，换手率为1.17%。公告显示，公司2024年员工持股计划首次授予部分第一个锁定期将于2025年12月3日届满，解锁条件已成就。2024年公司营业收入同比增长11.99%，达到业绩考核目标。首次授予实际认购人数为161人，其中152人为当前持有人。符合解锁条件的股份数量为8,512,251股，占公司总股本的0.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0201","BK0001","002793","BK0239","BK0132"],"gpt_icon":0},{"id":"2586430738","title":"罗欣药业（002793）披露为控股子公司提供担保的进展公告，11月28日股价上涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586430738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586430738?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:16","pubTimestamp":1764339370,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，罗欣药业报收于5.41元，较前一交易日上涨1.12%，最新总市值为58.84亿元。公司近日发布公告称，罗欣药业集团股份有限公司为控股子公司山东罗欣药业集团股份有限公司提供最高额人民币壹亿元的连带责任保证担保，用于其银行授信。本次担保后，公司对山东罗欣的担保余额为109,787.51万元，山东罗欣可用担保额度剩余49,148.40万元。山东罗欣生产经营正常，资信状况良好，公司对其具有实际控制权，担保风险可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800039846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0001","08058","BK0201","BK0132"],"gpt_icon":0},{"id":"2586426384","title":"罗欣药业：截止至2025年11月20日股东总户数为39,739","url":"https://stock-news.laohu8.com/highlight/detail?id=2586426384","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586426384?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:06","pubTimestamp":1764054384,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)11月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢罗欣药业回复：尊敬的投资者，您好！截止至2025年11月20日，公司股东总户数为39,739。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500016941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0239","BK0001","08058","BK0201","BK0132"],"gpt_icon":0},{"id":"2583504252","title":"罗欣药业（002793）披露选举非独立董事及修订多项议案，11月14日股价上涨3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583504252","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583504252?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:20","pubTimestamp":1763130037,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，罗欣药业报收于5.77元，较前一交易日上涨3.78%，最新总市值为62.75亿元。近日，罗欣药业发布公告称，公司于2025年11月14日召开2025年第六次临时股东会，审议通过了多项议案。其中包括修订公司章程、董事会议事规则，选举韩风生为第五届董事会非独立董事，以及关于公司2025年度向特定对象发行A股股票的相关议案。所有议案均获通过，会议召集召开程序合法，表决结果有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400041586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","BK0001","08058","BK0132","BK0239"],"gpt_icon":0},{"id":"2582907478","title":"股市必读：罗欣药业（002793）11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582907478","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582907478?lang=zh_cn&edition=full","pubTime":"2025-11-10 01:24","pubTimestamp":1762709052,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，罗欣药业报收于5.4元，上涨0.0%，换手率1.51%，成交量16.37万手，成交额8825.11万元。董秘最新回复投资者： 公司是否有生产幽门螺杆菌专用药品例如克拉霉素、甲硝唑、左氧氟沙星和阿莫西林董秘： 尊敬的投资者，您好。公司未生产利福特尼唑药，公司1类新药替戈拉生片与适当的抗生素联用以根除幽门螺杆菌。截止至2025年10月31日，公司股东总户数为43,927。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0001","08058","BK0201","BK0132"],"gpt_icon":0},{"id":"2581307039","title":"罗欣药业：替戈拉生片根除幽门螺杆菌","url":"https://stock-news.laohu8.com/highlight/detail?id=2581307039","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581307039?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:54","pubTimestamp":1762505655,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司是否生产幽门螺杆菌的利福特尼唑药罗欣药业回复：尊敬的投资者，您好。公司未生产利福特尼唑药，公司1类新药替戈拉生片与适当的抗生素联用以根除幽门螺杆菌。此前，公司开展的根除幽门螺杆菌感染的Ⅲ期临床试验证实了在中国幽门螺杆菌感染患者中，含替戈拉生的铋剂四联疗法幽门螺杆菌根除率（93.5%）优效于含艾司奥美拉唑的铋剂四联疗法（86.4%）。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700026082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0239","08058","BK0001","BK0132","BK0201"],"gpt_icon":0},{"id":"2581077856","title":"罗欣药业：截止至2025年10月31日，公司股东总户数为43,927","url":"https://stock-news.laohu8.com/highlight/detail?id=2581077856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581077856?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:36","pubTimestamp":1762504577,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月31日股东户数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2025年10月31日，公司股东总户数为43,927。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700025706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0239","BK0201","002793","BK0132"],"gpt_icon":0},{"id":"2580299668","title":"罗欣药业（002793）股东山东罗欣控股有限公司质押1.01亿股，占总股本9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580299668","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580299668?lang=zh_cn&edition=full","pubTime":"2025-11-03 18:33","pubTimestamp":1762166022,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业11月3日公开信息显示，股东山东罗欣控股有限公司向山东省国际信托股份有限公司合计质押1.01亿股，占总股本9.32%。质押详情见下表：截止本公告日，股东山东罗欣控股有限公司已累计质押股份1.37亿股，占其持股总数的57.95%。罗欣药业主营业务：医药产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300028120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0239","002793","BK0001","BK0132","BK0201"],"gpt_icon":0},{"id":"2578939122","title":"罗欣药业(002793)10月20日股东户数4.83万户，较上期增加26.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939122","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939122?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:35","pubTimestamp":1761644147,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2025年10月20日公司股东户数为4.83万户，较9月30日增加1.0万户，增幅为26.23%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年9月30日至2025年10月20日，罗欣药业区间涨幅为9.82%，在此期间股东户数增加1.0万户，增幅为26.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","BK0201","BK0132","08058","002793"],"gpt_icon":0},{"id":"2578622699","title":"图解罗欣药业三季报：第三季度单季净利润同比增长102.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578622699","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578622699?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:25","pubTimestamp":1761589554,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业2025年三季报显示，公司主营收入17.23亿元，同比下降8.37%；归母净利润2292.68万元，同比上升108.64%；扣非净利润491.82万元，同比上升101.73%；其中2025年第三季度，公司单季度主营收入6.46亿元，同比上升3.94%；单季度归母净利润523.18万元，同比上升102.96%；单季度扣非净利润261.76万元，同比上升101.48%；负债率61.65%，投资收益-439.44万元，财务费用4692.1万元，毛利率51.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"gpt_icon":0},{"id":"2577878057","title":"罗欣药业：截止至2025年9月30日股东总户数为38,267","url":"https://stock-news.laohu8.com/highlight/detail?id=2577878057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577878057?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:52","pubTimestamp":1761051165,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问9月30日收盘后的股东人数是多少？罗欣药业回复：尊敬的投资者，您好！截止至2025年9月30日，公司股东总户数为38,267。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100034696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","002793","BK0132","BK0239","BK0201","08058"],"gpt_icon":0},{"id":"2575790950","title":"10月16日罗欣药业（002793）涨停分析：创新药增长、业绩扭亏驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2575790950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575790950?lang=zh_cn&edition=full","pubTime":"2025-10-16 15:25","pubTimestamp":1760599518,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业10月16日涨停收盘，收盘价5.53元。此外，创新药板块整体活跃及政策利好预期亦形成板块共振效应。10月16日的资金流向数据方面，主力资金净流入7586.64万元，占总成交额34.17%，游资资金净流出3040.58万元，占总成交额13.69%，散户资金净流出4546.06万元，占总成交额20.47%。近5日资金流向一览见下表：该股为中药，幽门螺杆菌概念，医药概念热股，当日中药概念上涨0.57%，幽门螺杆菌概念概念上涨0.25%，医药概念上涨0.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600018398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK1574","002793","BK0201","06978","BK0001","BK1161","BK0132","08058","BK0239"],"gpt_icon":0},{"id":"2575408692","title":"股市必读：罗欣药业（002793）预计2025年1-9月每股收益盈利:0.0214元至0.0237元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575408692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575408692?lang=zh_cn&edition=full","pubTime":"2025-10-15 04:58","pubTimestamp":1760475488,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘，罗欣药业报收于4.88元，下跌0.41%，换手率1.28%，成交量13.94万手，成交额6854.2万元。来自业绩披露要点：罗欣药业预计2025年前三季度归母净利润为2,270万元至2,520万元，实现同比扭亏为盈。业绩披露要点业绩预告罗欣药业发布业绩预告，预计2025年1-9月每股收益盈利0.0214元至0.0237元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500004062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","BK0201","08058","BK0239","002793"],"gpt_icon":0},{"id":"2575291207","title":"罗欣药业(002793.SZ)发预盈，预计前三季度归母净利润2270万元至2520万元，扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2575291207","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575291207?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:04","pubTimestamp":1760439853,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)披露2025年前三季度业绩预告，公司预计归属于上市公司股东的净利润2270万元至2520万元，扭亏为盈;扣除非经常性损益后的净利润470万元至590万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"罗欣药业(002793.SZ)发预盈，预计前三季度归母净利润2270万元至2520万元，扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","002793"],"gpt_icon":0},{"id":"2571363073","title":"罗欣药业最新公告：拟定增募资不超过8.42亿元 用于创新药研发项目等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571363073","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571363073?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:50","pubTimestamp":1759150237,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称，公司计划向特定对象发行不超过3.26亿股A股股票，募集资金总额不超过8.42亿元，扣除发行费用后拟用于创新药研发项目、原料药改扩建及冻干车间技改项目以及补充流动资金。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900032801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK1161","BK0132","002793","06978","BK0201","08058","BK0001","159992"],"gpt_icon":0},{"id":"2570949099","title":"9月25日罗欣药业发布公告，股东减持884.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2570949099","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570949099?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:01","pubTimestamp":1758798085,"startTime":"0","endTime":"0","summary":"证券之星消息，9月25日罗欣药业发布公告《罗欣药业:关于持股5%以上股东的一致行动人减持计划实施完成的公告》，其股东温岭市大任企业管理有限公司于2025年8月1日至2025年9月24日间合计减持884.63万股，占公司目前总股本的0.8134%，变动期间该股股价下跌21.23%，截止9月24日收盘报5.12元。股东增减持详情见下表：根据罗欣药业2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500029287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","08058","BK0001","BK0239","002793","BK0201"],"gpt_icon":0},{"id":"2569718135","title":"罗欣药业：公司最新一期股东总户数为39,666","url":"https://stock-news.laohu8.com/highlight/detail?id=2569718135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569718135?lang=zh_cn&edition=full","pubTime":"2025-09-23 20:51","pubTimestamp":1758631911,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：最新一期股东数是多少罗欣药业回复：尊敬的投资者，您好！公司最新一期（2025年9月19日）公司股东总户数为39,666。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300034169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","BK0201","08058","BK0239","002793"],"gpt_icon":0},{"id":"2564396823","title":"罗欣药业：公司最新一期股东总户数为42,852","url":"https://stock-news.laohu8.com/highlight/detail?id=2564396823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564396823?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:51","pubTimestamp":1756903873,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月30日股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！公司最新一期（2025年8月29日）公司股东总户数为42,852。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300036331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0239","08058","BK0132","BK0001"],"gpt_icon":0},{"id":"2563681061","title":"股市必读：罗欣药业中报 - 第二季度单季净利润同比增长123.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563681061","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563681061?lang=zh_cn&edition=full","pubTime":"2025-08-29 04:57","pubTimestamp":1756414630,"startTime":"0","endTime":"0","summary":"截至2025年8月28日收盘，罗欣药业报收于5.68元，上涨1.97%，换手率2.74%，成交量29.72万手，成交额1.65亿元。业绩披露要点财务报告罗欣药业2025年中报显示，公司主营收入10.77亿元，同比下降14.45%；归母净利润1769.5万元，同比上升119.95%；扣非净利润230.07万元，同比上升102.14%。2025年第二季度，公司单季度主营收入5.95亿元，同比上升4.21%；单季度归母净利润1204.39万元，同比上升123.14%；单季度扣非净利润163.17万元，同比上升102.37%；负债率61.94%，投资收益85.74万元，财务费用3156.66万元，毛利率50.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900004509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luoxin.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东罗欣药业股份有限公司是原山东罗欣制药厂改制重组,由临沂罗欣医药有限公司控股,联合沈阳药科大学等共11家发起人共同发起设立的股份有限公司,是严格按照现代企业制度和国家GMP要求组建的制药企业,是国家级高新技术企业。公司经营范围:中西药品、医药原料药的研制、开发、生产、销售。公司建有冻干粉针剂、粉针剂、水针剂、固体制剂、头孢菌素类原料药、口服头孢系列产品等三十多条生产线,已全部通过国家GMP认证。","exchange":"SEHK","name":"罗欣药业","nameEN":"Shandong Luoxin Pharmaceutical Group"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,08058,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(08058)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(08058)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}